Clinician's Roundtable

Host: Maurice Pickard, MD Guest: Benjamin Hippen, MD Dr. Benjamin Hippen reviews the kidney transplantation policy failure in the United States. The cost is now 21 billion dollars in Medicare commitment to end-stage renal disease and 50 percent of those on the transplant waiting list will likely die before receiving an organ. This situation is getting worse by the day. Iran is the only country in...

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD Targeted and Individualized Therapies for Cancer. Where are we? What's on the horizon? Associate Dean of Clinical Research, Professor of Medicine and Director of the Genitourinary program at the University of Chicago Pritzker School of Medicine, Dr. Walter Stadler, cites the majority of patients struggling with the side effects - while grasping...

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD In 1971 Dr. Judah Folkman announced to the world that angiogenesis would be the Achilles heel of cancer-what's happened in the last 35 years? Dr. Walter M. Stadler, professor of medicine, director of Genitourinary Program, and associate dean of Clinical Research at the University of Chicago Medical Center joins host Dr. Bruce Bloom to fast forwa...

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD Associate Dean of Clinical Research, and professor of medicine and director of the genitourinary program at the University of Chicago Pritzker School of Medicine, Dr. Walter Stadler discusses his role in oversight of clinical research with your host, Dr. Bruce Bloom.

Host: Bruce Bloom, DDS, JD Guest: Walter Stadler, MD Host Dr. Bruce Bloom welcomes Dr. Walter Stadler, professor of medicine and director of the genitourinary program at the University of Chicago Pritzker School of Medicine. We are still working toward a highly effective treatment for hormone refractory prostate cancer. Could a paradoxical treatment with high-dose testosterone hold the key to a cu...

Host: Bruce Japsen Guest: Jeffrey Aronin, MBA At a time drug companies are looking for new answers when it comes to developing new products and having a difficult time, the pharmaceutical industry may be on the verge of a different tact: turning to physcians and their advocacy organizations. Jeffrey Aronin, president and CEO of Ovation Pharmaceuticals Inc. tells the Chicago Tribune's Bruce Japsen...

Host: Bruce Japsen Guest: Jeffrey Aronin, MBA It seems most drug-makers are making their biggest sales to doctors by pushing medicines for common conditions whether they be statins for cholesterol or proton pump inhibitors for heartburn. But drugs can actually take on blockbuster significance for specialized treatment groups where treatment options are limited. Jeffrey Aronin, president and CEO of...

Host: Bruce Japsen Guest: Jeffrey Aronin, MBA Not all drug companies are in pursuit of billion-dollar blockbuster drugs taken by millions of Americans. In fact, there are drugs treating rare conditions that wouldn't be sold on the market if not for a landmark piece of legislation known as the Orphan Drug Act, now 25 years old. Jeffrey Aronin, president and CEO of Ovation Pharmaceuticals Inc. tells...

Host: Larry Kaskel, MD Guest: Gerald Dorn, MD Should African American’s be treated with beta blockers to prevent heart failure? This has been a controversial question in the cardiovascular community. In this segment, Dr. Gerald Dorn of Washington University School of Medicine explains the biological mechanisms in which beta blockers offer protection from heart failure and what led him and his team...

Host: Michael Greenberg, MD Guest: Tangerine Brigham Dr. Michael Greenberg welcomes Tangerine Brigham, Deputy Director of Health for the San Francisco Department of Health and Director of "Healthy San Francisco," a landmark plan to provide health care to San Francisco's 73,000 uninsured city residents. Now available at multiple clinics across the city, this program is intended to give people a med...

Host: Leslie P. Lundt, MD Guest: Sandra Aamodt, PhD With a myriad of overlapping hormones and neurotransmitters involved, weight regulation is a complex task. While our bodies aim to stow away energy reserves for emergent times, our patients simultaneously try desperately to shed unwanted pounds. As Sandra Aamodt, PhD, author and former editor-in-chief of Nature Neuroscience , tells host Dr. Lesli...

Host: Leslie P. Lundt, MD Guest: Sandra Aamodt, PhD Our patients use their brains every moment of their lives. So do we! How well do you know your brain? You may be distressed at the answer. Dr. Sandra Aamodt, co-author along with Dr. Sam Wang of Welcome to Your Brain joins host Dr. Leslie Lundt to discuss common misconceptions about neurobiology.

Host: Leslie P. Lundt, MD Guest: Rama Maganti, MD Status epilepticus. What does that bring to mind? For most of us, we think of convulsions. But this is not always the case. Epileptologist Dr. Rama Maganti discusses nonconvulsive status epilepticus with host Dr. Leslie Lundt.

Host: Leslie P. Lundt, MD Guest: Stuart Vyse, PhD The American economic environment has drastically changed since the 1970s, and we now live in a world of material desire. Almost anything imaginable is available to purchase, and many of our patients choose to buy frivolities instead of spending their money wisely. How can understanding the psychology of debt help us to help them? Dr. Stuart Vyse w...

Host: Leslie P. Lundt, MD Guest: Stuart Vyse, PhD Over the last 30 years, debt, bankruptcy and now home foreclosures have risen to crisis proportions. In addition, the personal savings rate of Americans is at its lowest point since the Great Depression. What is wrong with us? Dr. Stuart Vyse will be discussing his latest book, Going Broke: Why Americans Can’t Hold on to their Money , with host Dr....

Host: Leslie P. Lundt, MD Guest: Dan Roam Tremendous leaps have been made in the science of vision giving us a better understanding of how we see. What do visual pathways teach us about the process of visual thinking? Host Dr. Leslie Lundt welcomes Dan Roam, author of The Back of the Napkin: Solving Problems and Selling Ideas with Pictures to discuss how we can use visual thinking techniques to im...

Host: Leslie P. Lundt, MD Guest: Dan Roam How can we communicate complex concepts to each other and our patients? Our guest today suggests using the back of a napkin. Dan Roam, author of The Back of the Napkin: Solving Problems and Selling Ideas with Pictures discusses with host Dr. Leslie Lundt how we can use visual thinking in our practices.

Host: Leslie P. Lundt, MD Guest: James Levenson, MD What is the latest on Sickle Cell Disease? Is pain the only issue in a sickle cell crisis? Dr. James Levenson joins host Dr. Leslie Lundt to discuss his research findings on sickle cell anemia.

Host: Leslie P. Lundt, MD Guest: James Levenson, MD Alcohol abuse is a common concern for many patients afflicted with chronic pain conditions. What are we learning about alcohol use specific to patients with sickle cell anemia? Is alcohol perhaps more help than hindrance? Dr. James Levenson, professor of psychiatry, medicine and surgery at the Virginia Commonwealth University School of Medicine,...

Host: Leslie P. Lundt, MD Guest: S. Thomas Carmichael, MD, PhD Stroke is the leading cause of adult disability. Stroke induces axonal sprouting and neurogenesis, this much we know. Controversy about neural repair persists – where in the brain do these axons sprout? How does this affect post-stroke recovery (or lack thereof)? Dr. S. Tom Carmichael joins host Dr. Leslie Lundt to explain the current...

Host: Leslie P. Lundt, MD Guest: Veronica Galvin, PhD We used to believe that neurogenesis only occurred in the developing nervous system. Recent research strongly disputes this idea. How might this knowledge change how we treat brain disease? Dr. Veronica Galvan joins host Dr. Leslie Lundt to discuss neurogenesis in the aging brain.

Host: Mark Nolan Hill, MD Guest: James Berenson, MD Advances in multiple myeloma therapy are suppressing the dreaded expectations of a daunting disease. How are the latest treatment modalities presenting new avenues for cancer therapy? How can we work to improve our awareness of the changing face of multiple myeloma? Dr. James Berenson, founding president and chief executive officer of the Institu...

Host: Mark Nolan Hill, MD Guest: James Berenson, MD Extended survival outcomes are becoming increasingly common after a diagnosis of multiple myeloma. What are some of the therapies responsible for these advances, and how far are we extending survival? Further, we’re learning that certain combination therapies are more effective for certain patients. How can we determine which patients are viable...

Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: Lu Wang, MD, PhD Dr. Lu Wang and her colleagues at Harvard Medical School have evaluated the eating habits of a large number of women in the Women’s Health Study and have shown an association between meat, grain and dairy intake and the development of hypertension. Dr. Wang will discuss some of the findings from these studies and give recommendati...

Host: Matthew J. Sorrentino, MD, FACC, FASH Guest: Lu Wang, MD, PhD Dr. Lu Wang and her colleagues at Harvard Medical School recently published an analysis from the Women’s Health Study showing that intake of low fat dairy products is associated with the lowest incidence of developing hypertension. Dr. Wang will describe her study and discuss the daily dose of dairy products to prevent hypertensio...